| |
|
| |
| DETAILS |
|
The Great Reset: Navigating Science, Capital & Policy at the Crossroads
The Great Reset: Navigating Science, Capital & Policy at the Crossroads
The pharma & biotech industries stand at an inflection point unseen since the genomic revolution. After years of pandemic-fueled growth & subsequent market turmoil, companies are redefining how they will survive & thrive. Capital is scarcer. Regulators worldwide are rewriting the rules. Breakthrough therapies in oncology, rare diseases & obesity are upending competition, even as supply chains fray & manufacturing nationalism redraws the global map.
In this moment of transformation, the industry's most consequential choices are being made. Which platforms will set the pace for the next decade? How will artificial intelligence reshape the economics of drug discovery? Can emerging companies secure the funding to deliver new treatments to patients? At Fierce JPM Week 2026, the sector's most influential leaders, investors & policymakers will convene to confront these questions & chart the course ahead.
|
|
|
|
|
|
|
|
